Skip to main content

Table 3 Study flow chart of the CDCS

From: Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study

Procedures

Visit time (month)

Baseline

6 ± 1

12 ± 1

18 ± 1

24 ± 1

Data release consent form

    

Demography data

    

Inclusion/exclusion criteria

    

Physical measurements (vital signs)

    

Smoking and alcohol drink status

    

Cardiovascular risk factors

    

Disease history

    

Concomitant medications

Hemoglobin, hematocrit

    

Serum total calcium, phosphorus, iPTH

25-OH Vit D, FGF23

 

 

Glucose, HDL-C, LDL-C, TC and TG

    

hs-CRP

    

Serum albumin, ferritin, alkaline phosphatase

    

Urea, uric acid, creatinine

    

ABI

    

Kt/V, dialysate calcium concentration

    

Dialysis vintage, dialysis frequency and modality, membrane type

    

EBCT or MDCT scan

   

Plain lateral lumbar radiograph

   

Echocardiography, LVMI/LVH

   

Clinical outcomes

 

  1. iPTH Intact parathyroid hormone, 25-OH Vit D serum 25-hydroxyvitamin D, FGF23 Fibroblast growth factor 23, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, TC Total Cholesterol, TG Triglyceride, hs-CRP High-sensitivity C-reactive protein, ABI Ankle-brachial index, EBCT Electron beam computed tomography, MDCT Multi-detector computed tomography, LVMI Left ventricular mass index, LVH Left ventricular hypertrophy